Growing investments in mRNA vaccine and therapeutic platforms, along with regulatory acceleration, are fueling steady global demand for high-purity raw materials.Austin, Nov. 04, 2025 (GLOBE NEWSWIRE) ...
Monday that a global tier-one pharmaceutical partner had started dosing patients in a phase one and two US clinical trial ...
Elegen has launched ENFINIA™ IVT Ready DNA, a cell-free gene synthesis platform that provides full-length linear DNA templates encoded poly(A) tails.
Investing.com -- 4basebio PLC (AIM:4BB) stock surged 6.9% on Monday after announcing that a global Tier 1 pharmaceutical partner has begun dosing patients in Phase I/II clinical trials using the ...
Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
A personalized mRNA vaccine for pancreatic cancer has shown early promise in a small phase 1 trial of 16 people. A mRNA-based cancer vaccine has shown impressive results in a small trial in patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback